First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Do hospitalized COVID-19 patients have long-term cognitive, psychiatric, or neurological complications? January 3, 2024 Study finds body composition impacts neurodegenerative disease risk July 28, 2024 Can ChatGPT aid in patient education for benign prostate enlargement? June 17, 2024
Do hospitalized COVID-19 patients have long-term cognitive, psychiatric, or neurological complications? January 3, 2024